News summary

TARGET Study Demonstrates Sustained Performance and Favorable Safety Profile of the Cardiovalve TR System in High-Risk Patients with Severe Tricuspid Regurgitation

Source: PR Newswire • Published: 22 Nov 2026, 15:30

Summarized by Masters of Longevity from PR Newswire.

TARGET found sustained tricuspid regurgitation reduction and improved right heart remodeling.

TARGET Study Demonstrates Sustained Performance and Favorable Safety Profile of the Cardiovalve TR System in High-Risk Patients with Severe Tricuspid Regurgitation
Key Takeaways
  • Study patients were high‑risk elderly with severe secondary TR.
  • Cardiovalve showed 76.9% none/trace TR at three years.
  • Enhanced delivery system was associated with fewer major complications.
Read the full article at PR Newswire ↗

Continue exploring

Recommended MoL Picks

MoL PickBiotin for Hair Growth: The Weak Evidence—and the Blood-Test Risk Most People MissBiotin deficiency can affect hair. That does not mean more biotin makes healthy hair grow—and high doses can distort important laboratory results.MoL PickApoB: The cholesterol signal LDL can missIn longevity medicine, the useful biomarkers are not always the exotic ones. ApoB is a relatively simple blood test that can sharpen cardiovascular prevention when LDL-C looks reassuring but particle burden remains high.MoL PickMelatonin and Heart Failure: What the Evidence Actually ShowsA 2025 study linked melatonin use with heart failure. A 2026 analysis found no significant association. Their different designs explain why the question remains open.